Filing Details
- Accession Number:
- 0000905718-19-000096
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-01 16:01:43
- Reporting Period:
- 2019-01-31
- Accepted Time:
- 2019-02-01 16:01:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1349929 | Cancer Genetics Inc | CGIX | Services-Medical Laboratories (8071) | 043462475 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1760938 | Glenn Michael Miles | 201 Route 17 North, 2Nd Floor C/O Cancer Genetics Inc. Rutherford NJ 07070 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2019-01-31 | 150,000 | $0.23 | 150,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
